Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Smith Michael AlexanderChief Legal Officer | Open-market sale | SELL | $242K 1,396 sh | Jan 8, 2026 traded Jan 6, 2026 | |
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner |
Open-market sale · 10b5-1 plan |
| SELL |
| $1.14M 5,647 sh |
| Jan 8, 2026 traded Jan 7, 2026 |
| 20 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $40K 202 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Gnanasambandam ChandrasekarEVP Product & CTO | Open-market sale · 10b5-1 plan | SELL | $87K 4,360 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 19 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $185K 946 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Robins Harlan SChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $164K 10.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 19 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $244K 1,255 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Payne AbbyChief People Officer | Open-market sale · 10b5-1 plan | SELL | $70K 3,582 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Rezvan MitraChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $76K 3,821 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 19 | Payne AbbyChief People Officer | Open-market sale · 10b5-1 plan | SELL | $186K 9,329 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 19 | Rezvan MitraChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $74K 3,782 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Gnanasambandam ChandrasekarEVP Product & CTO | Open-market sale · 10b5-1 plan | SELL | $83K 4,245 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Schmitt ChristopherGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $88K 4,507 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Schmitt ChristopherGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $202K 10.1K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Shipchandler KhozemaDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $1.50M 11.1K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $814K 4,099 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $841K 4,447 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $919K 4,610 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Issa Mohamed KhairieEVP, Head of US Oncology | Open-market sale · 10b5-1 plan | SELL | $1.18M 10.9K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $512K 2,543 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Gravier PierreCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $165K 2,139 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $712K 3,815 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $36K 9,730 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Borgeson BlakeDirector | Open-market sale · 10b5-1 plan | SELL | $959K 220.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $35K 9,722 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $33K 9,722 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 17 | Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $396K 5,149 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 15 | Peterson Neil W.CHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $450K 5,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 15 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $216K 1,121 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 14 | Schlosser MarioDirector, President of Technology & CTO | Open-market sale · 10b5-1 plan | SELL | $1.31M 77.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 14 | Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $234K 3,016 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Smith Chad M.Pres & COO, Better Mortgage | Open-market sale · 10b5-1 plan | SELL | $100K 2,843 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 12 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $493K 2,830 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 12 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $830K 4,783 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 12 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $280K 1,615 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 11 | Shipchandler KhozemaDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $290K 2,181 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 11 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $143K 1,900 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 11 | Peters John SheldonChief Insurance Officer | Open-market sale · 10b5-1 plan | SELL | $800K 10.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 11 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $116K 1,500 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $167K 957 sh | Jan 8, 2026 traded Jan 6, 2026 |